You are here: All Products  > BeyondSpring, a US-China Pharma, Files for $100 Million IPO

BeyondSpring, a US-China Pharma, Files for $100 Million IPO

Price: $5.00
Available
Get instant access to this article for unlimited viewing and/or downloading for seven days.

Back to products